B. Braun Launches New Patient Website

BETHLEHEM, Pa., April 9, 2013 -- B. Braun Medical Inc. (B.Braun) launched a new website for dialysis patients. The website, which can be found at www.bbraun-dialysis.com, provides information about living with dialysis. Patients will find useful tips on everyday topics, planning an overseas vacation, and be able to utilize this website to locate the addresses of over 200 dialysis centers worldwide to arrange dialysis at individual centers. The website also provides tasty recipes and dietary advice to ensure that patients on restricted diets can also enjoy balanced and varied meals. They can also access videos and other information about various kidney-related topics, as well as a useful frequently asked questions section.

"Patients who undergo dialysis on a weekly basis know the challenges of trying to live a normal and productive life," said Sam Amory, Vice President, Avitum Division at B.Braun. "We believe this new website provides pertinent information for patients living with dialysis," added Amory.

B.Braun has been a leading provider of dialysis care products for more than 30 years. B.Braun does much more than simply manufacture and distribute top quality dialysis machines, dialyzers and disposables. The company offers an integrated system composed of perfectly harmonized components. These include a wide range of therapy options, software solutions for optimal and economical dialysis treatment, and full technical service support. Customers profit from the expertise of an all-round system supplier with comprehensive knowledge and experience of every aspect of the dialysis situation– from research to manufacturing to therapy.

About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun group of companies includes B.Braun, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania, with its global headquarters based in Melsungen, Germany. It employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.bbraunusa.com.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.